Doug Hoey is CEO, National Community Pharmacists Association.
Independent Pharmacies Must Expand Services to Stay Afloat | AAP 2025
At AAP 2025, Douglas Hoey, RPh, MBA, CEO of NCPA, discussed what pharmacies can do to increase revenue and avoid shutting their doors.
Q&A: Douglas Hoey on PBM Reform, Optum Rx Cost-Plus Announcement | AAP 2025
At AAP 2025, Douglas Hoey, CEO of NCPA, discussed the possibility of PBM reform under the new administration and his take on Optum Rx’s plans to introduce a cost-plus reimbursement model.
Medicare Drug Price Negotiation Could Expose Pharmacies to Significant Financial Risk | AAP 2025
At the American Associated Pharmacies Annual Conference, Douglas Hoey, RPh, MBA, discussed what needs to change in the program so that it does not hurt pharmacies and patients.
PBM Reform Delays Continue to Negatively Impact Pharmacies | AAP 2025
A conversation with Douglas Hoey, CEO of the National Community Pharmacists Association, at the American Associated Pharmacies 2025 Annual Conference.
Alarm Bells are Ringing: Medicare Drug Price Negotiation Program Will Fail Without Changes
If CMS doesn’t reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.
Opinion: PBM Hocus Pocus Harming Seniors, Small Business Pharmacies
Policymakers have the power to get pharmacy benefit managers under control.
Opinion: A New Toolkit to Fight Opioid Abuse
What one pharmacist says the AAOA Pharmacy Toolkit can do to help combat the opioid epidemic.
The MAC pricing system must be fixed
The time has come for pharmacists to work on reforming the maximum allowable costs put forth by the pharmacy benefit managers